Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Cambrex Corporation has announced the completion and validation of a $50 million state-of-the-art production and warehousing expansion at its cGMP Charles City, Iowa site. The investment in capacity and capabilities was made in reflection of strong ...
read more
Recipharm has announced an €18 million investment to expand its blow fill seal (BFS) capacity at its site in Kaysersberg, France
read more
Worldwide Clinical Trials will host a free webinar, titled “Are We Moving Toward ‘Siteless’ Clinical Trials? Exploring the Current and Future Potential of Home-Based Studies,” on Thursday, July 14, 2016 at 11 am ET. Leading the discussion will be ...
read more
Ligand Pharmaceuticals has entered into a worldwide license agreement with Gilead Sciences, Inc. Under the license, Gilead will be able to use the OmniRat®, OmniMouse® and OmniFlic® platforms to discover fully human mono- and bispecific antibodies to...
read more
Recipharm has appointed Ann Flodin as General Manager of its wholly owned new subsidiary Recipharm Laboratories Inc. in Research Triangle Park, North Carolina, USA, formerly Cirrus Pharmaceuticals Inc.
read more
Evotec AG has announced a collaboration with Antibiotic Research UK to identify alternative means of treating infections that are resistant to currently available antibiotics.
read more
AMRI announced that it has completed the acquisition of Prime European Therapeuticals S.p.A., also known as "Euticals", a privately-held company headquartered in Lodi, Italy, specializing in custom synthesis and the manufacture of active ...
read more
BioInvent International has signed an agreement with Alligator Bioscience AB to provide process development and manufacturing services for Alligator’s new bispecific antibody, ADC-1015.
read more
Aptuit and Dimension Therapeutics have announced a strategic partnership agreement under which Aptuit will support GLP IND-enabling studies for select rare disease programs at Dimension. Three key integrated development projects have initiated under ...
read more
Catalent Pharma Solutions has announced the appointment of Stephen Vanni as General Manager of the company’s Braeside facility in Melbourne, Australia.
read more
Orange Business Services has signed a contract with Merck to deploy a 200-site, next-generation network that will support its digital transformation initiatives. The network and related services will reduce complexity throughout Merck’s ...
read more
Radiant Clinical Research is expanding the scope of its Central Nervous System (CNS) studies. This expansion is in response to a growing need for qualified sites that have the expertise to conduct pharmaceutical trials for the treatment of ...
read more
Medidata a global provider of cloud-based solutions for clinical research, has signed a multi-year enterprise deal with Hanmi Pharmaceutical, one of South Korea's leading drug makers.
read more
Vertex Pharmaceuticals Incorporated and Modena Therapeutics have entered into an exclusive research collaboration and licensing agreement aimed at the discovery and development of messenger Ribonucleic Acid (mRNA) Therapeutics™ for the treatment of ...
read more
Patheon, a global provider of pharmaceutical development and manufacturing services, announced that Patrick Glaser was appointed senior vice president of the company’s small molecule active pharmaceutical ingredient (API) business.
read more